Summary:
The purpose of this study is to assess the efficacy of a medication used to treat high grade cervical intraepithelial neoplasia (CIN)grade 2 or 3 associated with High Risk HPV infection
Qualified Participants Must:
• Be 18 years of age or older
•
Have a diagnosis of CIN 2/3 within the last 2 months
Qualified Participants May Receive:
Study medication, physical exams and laboratories at no cost. You may also receive compensation for time and travel.